发明授权
- 专利标题： NOVEL ORAL FORMS OF A PHOSPHONIC ACID DERIVATIVE
- 专利标题（中）： 口服膦的新形式
-
申请号： EP10805114.5申请日： 2010-07-30
-
公开(公告)号： EP2458996B1公开(公告)日： 2016-09-07
- 发明人: HANNA, Mazen , SHAN, Ning , CHENEY, Miranda , WEYNA, David
- 申请人： Thar Pharmaceuticals, Inc.
- 申请人地址： 730 William Pitt Way Pittsburgh, PA 15238 US
- 专利权人： Thar Pharmaceuticals, Inc.
- 当前专利权人： Thar Pharmaceuticals, Inc.
- 当前专利权人地址： 730 William Pitt Way Pittsburgh, PA 15238 US
- 代理机构： Eder, Michael
- 优先权： US230234P 20090731
- 国际公布： WO2011014781 20110203
- 主分类号： A01N57/00
- IPC分类号： A01N57/00 ; A61K31/675 ; C07F9/6506
摘要：
Novel solution complexes of zoledronic acid are described which give rise to improved properties of zoledronic acid. The invention includes aqueous solution and molecular complexes of zoledronic acid with and optical isomers of asparagine, histidine, arginine and proline as well as pharmaceutical complexes containing them and methods of treatment using them.
公开/授权文献
- EP2458996A1 NOVEL ORAL FORMS OF A PHOSPHONIC ACID DERIVATIVE 公开/授权日：2012-06-06
信息查询
